National Invited Speakers - Radiation Oncology

David Ball

Professor David Ball

Professor David Ball is the Chair of the multi-disciplinary Lung Service at Peter Mac and a Professorial Fellow of the University of Melbourne. He has over 200 publications in the peer reviewed literature. He is currently Chair of the Australian Lung Cancer Guidelines Working Party and a member of the Mesothelioma Guidelines Working Group. David Ball is Editor-in-Chief of the Journal of Medical Imaging and Radiation Oncology and on the editorial board of Clinical Lung Cancer, and previously Journal of Thoracic Oncology and Nature Reviews Clinical Oncology. He has been a member of the International Association for the Study of Lung Cancer (IASLC) staging and prognostic factors committee, which made recommendations for the 7th and 8th edition of the TNM staging of lung cancer. He is an editor of the IASLC textbook: The multidisciplinary approach to Thoracic Oncology. He has received the following honours: IASLC merit award in 2011, Gold Medal of Royal Australian and New Zealand College of Radiologists in 2011 and the Tom Reeve Award of Clinical Oncology Society of Australia, 2012. Professor Ball’s research interests include lung cancer staging, tumour imaging and definition, image guided stereotactic ablative body radiotherapy and combined modality therapy.

 

ASTROIP060 20180827.2DX 9948 v2

A/Prof June Corry

Associate Professor June Corry is an internationally recognised Head and Neck radiation oncologist. She has dual medical oncology and radiation oncology qualifications. She was the Head of the Peter MacCallum Cancer Center H&N Service for 15 years and is now working with GenesisCare St Vincents Hospital Melbourne. She has served as the President of the ANZHNCS, TROG Executive/Publications/ANROTAT committees, and the Chair of WCMICS and VCOG. She was a founding member of IAOO. She is on the Editorial board of JCO, IJROBP, OO and H&N journals. She has published over 120 manuscripts in peer review journals and multiple book chapters. She has a strong belief in collaborative clinical research and patient advocacy.

Radiation Oncology Dr James Fergusson

Dr James Fergusson

Senior Staff Specialist | Hepatobiliary and General Surgeon, The Canberra Hospital

Dr James Fergusson is a Hepatobiliary and General Surgeon who specializes in treating patients with liver tumours.  He is based at the Canberra Hospital as a Senior Staff Specialist. 

 

Tomas Kron

Prof Tomas Kron

Prof Tomas Kron was born and educated in Germany. After his PhD he migrated to Australia in 1989 where he commenced his career in radiotherapy physics. After working in Canada for 4 years, Tomas became principal research physicist at Peter MacCallum Cancer Centre in Melbourne in 2005. Ten years later he was appointment there as Director of Physical Sciences. Tomas holds academic honorary appointments on a professorial level at Monash, RMIT and Wollongong Universities. He has an interest in dosimetry of ionising radiation, image guided radiotherapy, clinical trials and education of medical physicists demonstrated by more than 250 papers in refereed journals and more than 10 books and book chapters. Over the years Tomas Kron has maintained an interest in education reflected in 75 invited conference presentations. Tomas serves on the editorial board of several international journals and was awarded the Distinguished Services Award of the Australasian College of Physical Scientists and Engineers in Medicine (ACPSEM). In 2014 he was awarded an Order of Australia Medal (OAM) for services to medicine, research and education.

 

Jarad Martin

A/Prof Jarad Martin

Jarad Martin is a Radiation Oncologist and departmental Director of Research at the Calvary Mater Newcastle. He also holds a VMO appointment with Genesis Cancer Care. After completing training at the Peter MacCallum Cancer Centre, he undertook a clinical research fellowship at the Princess Margaret Hospital in Toronto, winning their excellence in research prize. His primary interests are in urologic and gastrointestinal cancers, as well as using radiotherapy to treat benign diseases. Jarad assumed the Australasian Primary Investigator role for the successful PROFIT clinical trial which showed a new 4 week regimen gave equivalent outcomes to a conventional 8 week approach. He relocated to Newcastle in 2012 and continued to develop a number of senior roles in national bodies including TROG, ANZUP, FROGG and FRANZCR. Jarad has several current multicentre prospective clinical trials and >80 peer reviewed publications.

 Radiation Oncology Michael Penniment
A/Prof Michael Penniment
 

A/Prof Michael Penniment is a Senior Radiation Oncologist with interests in the application of new technologies in radiotherapy and the provision of services to rural and remote areas. He was a foundation consultant at the North Queensland Oncology service and then planned and established the Alan Walker Cancer Care Centre (AWCCC) in Darwin.

The AWCCC has just completed a successful review of 7 years of operation and, under A/Prof Penniment’s lead, is a good example of Federal capital infrastructure funding excellence in cancer treatment. His unit at the new RAH was the first service to open at RAH, one month ahead of schedule.

He was involved in Australia’s first National Proton Advisory Committee and has since lead the SA Government team looking to establish a centre in the new Adelaide health precinct. He completed his MBA studies, during a period where his team were involved in evaluating new efficient synchrotron proton therapy solutions.

He has held key positions in the College (RANZCR) such as Government and Regulatory Affairs Committee (2003-2010), Faculty Board member (2006-2011), Education Board (1997-2006, 2011-2013), Economics and Workforce Committee (RANZCR 2011-2013),and is currently a lead in the Particle therapy group within the faculty.

A/Prof Penniment has been invited to join the founding board of the Asian Particle Therapy Society linking Australia with the teams in Japan, Korea, China and Taiwan.

He is involved in a number of national and international research projects, in particular in the areas of business planning for new radiation facilities, improving indigenous cancer care, and quality of life in cancer treatment. In 2017 he was engaged to review the radiation oncology operations of a number of public centres in Victoria, looking specifically at the sustainability of their business model and to revise their leadership structure and service delivery.

A/Prof Penniment was awarded the TROG excellence in trial research for his palliative oesophageal trial following on from selection for Best of ASTRO in the USA in 2014, and ASCO GIT 2015.

 

Shankar Siva

A/Prof Shankar Siva

A/Prof Shankar Siva is a staff radiation oncologist at the Peter MacCallum Cancer Centre. He has over 100 peer-reviewed manuscript publications and been a podium presenter at over 50 national and international scientific meetings. He completed his PhD investigating high-tech radiation delivery and radiation biology in the context of lung cancers. He leads the stereotactic ablative body radiotherapy (SABR) program at the Peter MacCallum Cancer Centre, and published the first original research employing the SABR technique in Australia. He has an international research profile in SABR, lung and kidney cancers.

 

Radiation Oncology Iain Ward

Dr Iain Ward

Iain Ward is a radiation oncologist at the Canterbury Regional Cancer and Haematology Service and at St George’s Cancer Care Centre in Christchurch, specialising in the treatment of gastrointestinal cancer, head and neck cancer and soft tissue sarcoma.   After graduating from the University of Otago, he trained in medical oncology at Christchurch Hospital and in radiation oncology at the Peter MacCallum Cancer Centre, followed by clinical fellowships at the Princess Margaret Hospital in Toronto.

Since going to school in Samoa and his medical elective in Vanuatu, he has been interested in healthcare in Low and Middle Income Countries (LMICs).  His activities with the Asia-Pacific Radiation Oncology Special Interest Group include supporting the new National Cancer Centre in Phnom Penh and developing a regional video tumour board for LMICs.